{"id":5050,"date":"2023-05-01T18:06:42","date_gmt":"2023-05-01T22:06:42","guid":{"rendered":"https:\/\/ccna-ccnv.ca\/ccna_publication\/dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2\/"},"modified":"2024-12-03T14:58:25","modified_gmt":"2024-12-03T19:58:25","slug":"dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2","status":"publish","type":"ccna_publication","link":"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2\/","title":{"rendered":"Dementia Risk Prediction in a Longitudinal Geriatric Parkinson&rsquo;s Disease Cohort: Evaluation and Application of the Montreal Parkinson Risk of Dementia Scale"},"content":{"rendered":"<h2 class=\"title\">Abstract<\/h2>\n<div id=\"eng-abstract\" class=\"abstract-content selected\">\n<p><strong class=\"sub-title\">Background:\u00a0<\/strong>Parkinson&rsquo;s disease (PD) increases risk for dementia and cascading adverse outcomes. The eight-item Montreal Parkinson Risk of Dementia Scale (MoPaRDS) is a rapid, in-office dementia screening tool. We examine predictive validity and other characteristics of the MoPaRDS in a geriatric PD cohort by testing a series of alternative versions and modelling risk score change trajectories.<\/p>\n<p><strong class=\"sub-title\">Methods:\u00a0<\/strong>Participants were 48 initially non-demented PD patients (Mage = 71.6 years, range = 65-84) from a three-year, three-wave prospective Canadian cohort study. A dementia diagnosis at Wave 3 was used to stratify two baseline groups: PD with Incipient Dementia (PDID) and PD with No Dementia (PDND). We aimed to predict dementia three years prior to diagnosis using baseline data for eight indicators that harmonized with the original report, plus education.<\/p>\n<p><strong class=\"sub-title\">Results:\u00a0<\/strong>Three MoPaRDS items (age, orthostatic hypotension, mild cognitive impairment [MCI]) discriminated the groups both independently and as a composite three-item scale (area under the curve [AUC] = 0.88). The eight-item MoPaRDS reliably discriminated PDID from PDND (AUC = 0.81). Education did not improve predictive validity (AUC = 0.77). Performance of the eight-item MoPaRDS varied across sex (AUCfemales = 0.91; AUCmales = 0.74), whereas the three-item configuration did not (AUCfemales = 0.88; AUCmales = 0.91). Risk scores of both configurations increased over time.<\/p>\n<p><strong class=\"sub-title\">Conclusions:\u00a0<\/strong>We report new data on the application of the MoPaRDS as a dementia prediction tool for a geriatric PD cohort. Results support the viability of the full MoPaRDS, and indicate that an empirically determined brief version is a promising complement.<\/p>\n<\/div>\n<p><strong class=\"sub-title\">Keywords:\u00a0<\/strong>Montreal Parkinson Risk of Dementia Scale (MoPaRDS); Parkinson\u2019s disease; incipient dementia; longitudinal change; risk factors.<\/p>\n","protected":false},"author":19,"featured_media":0,"template":"","meta":{"_acf_changed":false},"studies-relation":[],"class_list":["post-5050","ccna_publication","type-ccna_publication","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dementia Risk Prediction in a Longitudinal Geriatric Parkinson&#039;s Disease Cohort: Evaluation and Application of the Montreal Parkinson Risk of Dementia Scale - CCNA - CCNV<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dementia Risk Prediction in a Longitudinal Geriatric Parkinson&#039;s Disease Cohort: Evaluation and Application of the Montreal Parkinson Risk of Dementia Scale - CCNA - CCNV\" \/>\n<meta property=\"og:description\" content=\"Abstract Background:\u00a0Parkinson&rsquo;s disease (PD) increases risk for dementia and cascading ...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2\/\" \/>\n<meta property=\"og:site_name\" content=\"CCNA - CCNV\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-03T19:58:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ccna-ccnv.ca\/wp-content\/uploads\/2025\/01\/CCNA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2\/\",\"url\":\"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2\/\",\"name\":\"Dementia Risk Prediction in a Longitudinal Geriatric Parkinson's Disease Cohort: Evaluation and Application of the Montreal Parkinson Risk of Dementia Scale - CCNA - CCNV\",\"isPartOf\":{\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/#website\"},\"datePublished\":\"2023-05-01T22:06:42+00:00\",\"dateModified\":\"2024-12-03T19:58:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ccna-ccnv.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dementia Risk Prediction in a Longitudinal Geriatric Parkinson&#8217;s Disease Cohort: Evaluation and Application of the Montreal Parkinson Risk of Dementia Scale\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/#website\",\"url\":\"https:\/\/ccna-ccnv.ca\/fr\/\",\"name\":\"Canadian Consortium on Neurodegeneration in Aging\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/#organization\"},\"alternateName\":\"CCNA - CCNV\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ccna-ccnv.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/#organization\",\"name\":\"Canadian Consortium on Neurodegeneration in Aging\",\"alternateName\":\"CCNA - CCNV\",\"url\":\"https:\/\/ccna-ccnv.ca\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ccna-ccnv.ca\/wp-content\/uploads\/2025\/01\/ccna-logo-on-white-background.jpg\",\"contentUrl\":\"https:\/\/ccna-ccnv.ca\/wp-content\/uploads\/2025\/01\/ccna-logo-on-white-background.jpg\",\"width\":696,\"height\":696,\"caption\":\"Canadian Consortium on Neurodegeneration in Aging\"},\"image\":{\"@id\":\"https:\/\/ccna-ccnv.ca\/fr\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dementia Risk Prediction in a Longitudinal Geriatric Parkinson's Disease Cohort: Evaluation and Application of the Montreal Parkinson Risk of Dementia Scale - CCNA - CCNV","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2\/","og_locale":"fr_CA","og_type":"article","og_title":"Dementia Risk Prediction in a Longitudinal Geriatric Parkinson's Disease Cohort: Evaluation and Application of the Montreal Parkinson Risk of Dementia Scale - CCNA - CCNV","og_description":"Abstract Background:\u00a0Parkinson&rsquo;s disease (PD) increases risk for dementia and cascading ...","og_url":"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2\/","og_site_name":"CCNA - CCNV","article_modified_time":"2024-12-03T19:58:25+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/ccna-ccnv.ca\/wp-content\/uploads\/2025\/01\/CCNA.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2\/","url":"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2\/","name":"Dementia Risk Prediction in a Longitudinal Geriatric Parkinson's Disease Cohort: Evaluation and Application of the Montreal Parkinson Risk of Dementia Scale - CCNA - CCNV","isPartOf":{"@id":"https:\/\/ccna-ccnv.ca\/fr\/#website"},"datePublished":"2023-05-01T22:06:42+00:00","dateModified":"2024-12-03T19:58:25+00:00","breadcrumb":{"@id":"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ccna-ccnv.ca\/fr\/ccna_publication\/dementia-risk-prediction-in-a-longitudinal-geriatric-parkinsons-disease-cohort-evaluation-and-application-of-the-montreal-parkinson-risk-of-dementia-scale-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ccna-ccnv.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Dementia Risk Prediction in a Longitudinal Geriatric Parkinson&#8217;s Disease Cohort: Evaluation and Application of the Montreal Parkinson Risk of Dementia Scale"}]},{"@type":"WebSite","@id":"https:\/\/ccna-ccnv.ca\/fr\/#website","url":"https:\/\/ccna-ccnv.ca\/fr\/","name":"Canadian Consortium on Neurodegeneration in Aging","description":"","publisher":{"@id":"https:\/\/ccna-ccnv.ca\/fr\/#organization"},"alternateName":"CCNA - CCNV","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ccna-ccnv.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/ccna-ccnv.ca\/fr\/#organization","name":"Canadian Consortium on Neurodegeneration in Aging","alternateName":"CCNA - CCNV","url":"https:\/\/ccna-ccnv.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/ccna-ccnv.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ccna-ccnv.ca\/wp-content\/uploads\/2025\/01\/ccna-logo-on-white-background.jpg","contentUrl":"https:\/\/ccna-ccnv.ca\/wp-content\/uploads\/2025\/01\/ccna-logo-on-white-background.jpg","width":696,"height":696,"caption":"Canadian Consortium on Neurodegeneration in Aging"},"image":{"@id":"https:\/\/ccna-ccnv.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/ccna-ccnv.ca\/fr\/wp-json\/wp\/v2\/ccna_publication\/5050","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ccna-ccnv.ca\/fr\/wp-json\/wp\/v2\/ccna_publication"}],"about":[{"href":"https:\/\/ccna-ccnv.ca\/fr\/wp-json\/wp\/v2\/types\/ccna_publication"}],"author":[{"embeddable":true,"href":"https:\/\/ccna-ccnv.ca\/fr\/wp-json\/wp\/v2\/users\/19"}],"wp:attachment":[{"href":"https:\/\/ccna-ccnv.ca\/fr\/wp-json\/wp\/v2\/media?parent=5050"}],"wp:term":[{"taxonomy":"studies-relation","embeddable":true,"href":"https:\/\/ccna-ccnv.ca\/fr\/wp-json\/wp\/v2\/studies-relation?post=5050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}